Compare Comfort Systems USA Inc (FIX) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Comfort Systems USA Inc vs Summit Therapeutics Inc — how do they compare? Comfort Systems USA Inc trades at $1,664.97 (market cap $61.14B), while Summit Therapeutics Inc trades at $13.84 (market cap $11.70B). The key difference: Comfort Systems USA Inc is far larger — about 5.2× Summit Therapeutics Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| FIX | SMMT | |
|---|---|---|
Market Cap | $61.14B | $11.70B |
Sector | Technology | Health |
52-Week High | $2.07K | $29.32 |
52-Week Low | $532.14 | $13.05 |
Enterprise Value | $60.42B | $11.12B |
Dividend Yield | 0.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,655.80, down 6.72% over the past day, amid a bearish technical signal. The stock shows strong fundamentals with Q1 2026 EPS beating estimates at $10.51 versus $6.81 expected, and revenue growth projected from $9.10B in 2025 to $10.10B in 2026. Analyst consensus remains bullish with a $2,100 price target, supported by robust cash flow and a 53.29% ROE.
Outlook is positive due to AI infrastructure demand and record backlog, though high valuation multiples (P/E 50.14) and execution risks from rapid growth pose challenges. The stock offers growth potential but requires monitoring of margin sustainability and competitive pressures in the contracting services sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
